Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The platelet glycoprotein Ib–IX–V complex (GPIb-IX-V) is a membrane receptor complex found exclusively on the surface of platelets and their precursor cells, megakaryocytes. It plays a central role in hemostasis by mediating platelet adhesion to sites of vascular injury. The complex consists of four distinct subunits: GPIbα, GPIbβ, GPIX, and GPV. Its primary function is to bind von Willebrand factor (VWF) exposed at sites of vascular injury under high shear stress conditions, triggering platelet arrest, activation, and aggregation. Deficiency or dysfunction leads to Bernard-Soulier syndrome. It is an attractive target for anti-thrombotic therapies.
Inhibition of platelet adhesion to von Willebrand factor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet Glycoprotein Ib-IX-V Complex (GPIb-IX-V).